Morphic Holding Inc (NASDAQ:MORF)
| 51.37 Delayed Data As of Sep 21 |  +0.58 / +1.14%Today’s Change | 23.03 Today|||52-Week Range 63.08 | +92.04% Year-to-Date |
Latest MORF News | Press Releases
No recent news for Morphic Holding Inc.
Today’s Trading
| Previous close | 50.79 |
| Today’s open | 50.08 |
| Day’s range | 50.00 - 52.70 |
| Volume | 14,849 |
| Average volume (3 months) | 426,170 |
| Market cap | $2.5B |
Data as of 3:59pm ET, 09/21/2023
Growth & Valuation
| Earnings growth (last year) | +41.96% |
| Earnings growth (this year) | -133.23% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +257.72% |
| P/E ratio | NM |
| Price/Sales | 14.40 |
| Price/Book | 5.88 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZLABZai Lab Ltd | -1.43 | -5.63% |
| ---- | ||
| ---- | ||
| ---- |
Data as of 3:59pm ET, 09/21/2023
Financials
| Next reporting date | November 14, 2023 |
| EPS forecast (this quarter) | -$0.90 |
| Annual revenue (last year) | $70.8M |
| Annual profit (last year) | -$59.0M |
| Net profit margin | -83.38% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
